From powder to implant

Quality assurance for additively manufactured implants.

Basics of Confocal Laser Scanning Microscopy

Learn about the principle of confocal fluorescence microscopy.

J & J och Bayer säger upp personal

Närmare 300 jobb inom läkemedelsindustrin i New Jersey försvinner när Johnson & Johnson och Bayer skär ner.

Rovtidskriftsjägaren om sin ärkefiende: ”Ondskans imperium”

Han myntade begreppet rovtidskrifter och gjorde ett första försök att kartlägga deras utbredning. Nu berättar bibliotekarien Jeffrey Beall om konsekvenserna det...

Nytt varsel på BMS – ska spara 1,5 miljarder

Bristol Myers Squibb, BMS, varslar 195 anställda efter att läkemedelsbolaget genomför ytterligare ett besparingspaket.

Here are the pharmaceutical companies best prepared for AI

How well prepared are pharmaceutical companies in the field of artificial intelligence? That is what a new analysis has tried to evaluate.

JMP Statistical Discovery

Anna Törner: ”If I fall seriously ill, I’ll move to Finland”

”It is both undignified and undemocratic that cancer patients must travel to Finland to uphold a façade of fairness that does not truly exist”, Anna Törner writes in a column.

Rise and Scantox cease conducting animal testing in Stockholm

Access to in vivo toxicology services is significantly decreasing in the Stockholm area as Rise shuts down animal testing and Scantox reorganizes. ”The costs ar...

Hon är ny på Gradientech

Diagnostikbolaget Gradientech har rekryterat AnnaLotta Schiller Vestergren till tjänsten som Chief Commercial Officer.

The Swedish innovation model: “There is a paradox”

It is often said that Sweden is strong when it comes to innovation, but how well are we turning that innovation into actual medicines?

Thomas Eldered: ”Innovation is the key”

Thomas Eldered speaks in a web clip about the challenges facing the life science sector in the future and what he, as an investor, finds most interesting in new companies.

Who pays for Rebecca Doe – and all of us?

Anna Törner on how easily we get used to the idea that healthcare is free - when it really is about how and who pays for it

Joy at Egetis after positive CHMP opinion – ”The single most important milestone”

Stockholm-based Egetis Therapeutics has received a positive CHMP opinion for Emcitate, which could become the first approved treatment for the rare disease MCT8 deficiency."

This years Nobel prize in medicine – “Changed the understanding of how genes are controlled”

This year’s Nobel Prize in Physiology or Medicine goes to the discovery that small RNA molecules, known as microRNAs, control how genes are regulated. Understan...

Partial court victory for entrepreneur who lost his company

Swedish life science entrepreneur Mikael Kubista has won the first round against a law firm that he, along with other co-owners, sued for negligent advice in co...

ZEISS Metrology Expert Tips

New video series provides valuable expert knowledge.

Nytt europeiskt patent skyddar formulering från Index Pharmaceuticals

Index Pharmaceuticals har beviljats ett nytt europeiskt formuleringspatent för sin läkemedelskandidat cobitolimod som utvärderas som behandling av ulcerös kolit...

“What is important is to create an overview and understanding from different perspectives”

Scientist Jochen Schwenk analyses blood proteins using proteomics to improve our understanding of disease and health. This year, he is moderating the Lab & Diag...

Omvänt förvärv ska ta Flerie till börsen – ”Viktigt steg i bolagets plan”

Läkemedelsinvesteraren Flerie Invest tar en genväg till börsen genom ett omvänt förvärv av forskningsbolaget Index Pharmaceuticals.

What will be the next big hype after obesity? – An expert panel highlighted their top picks

What will be the next big trend in life science? Everything from Alzheimer’s, Crispr and Omics were highlighted when the issue was debated at this year’s major ...

Exploring Molecular Dynamics with Raster Image Correlation Spectroscopy

Case study by ZEISS Microscopy.

Starka resultat för genterapi – pausas ändå

En ny genterapi förbättrade synen hos elva av tolv patienter med en extremt sällsynt ärftlig ögonsjukdom. Men trots de starka resultaten i en klinisk studie har...

Come see us at the upcoming events!

We have some upcoming events where you can see our latest products live!